Open Market Insiders Trades - Buys only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
PRSO
|
James Sullivan
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 1,502 Added 18.77% |
$5,843
$3.89 p/Share
|
Feb 28
2011 |
|
IDIX
|
Ag Novartis |
BUY
Open market or private purchase
|
Indirect | 20,993 Added 0.01% |
$76,205
$3.63 p/Share
|
Feb 25
2011 |
|
ISR
|
Dwight William Babcock
CEO |
BUY
Open market or private purchase
|
Direct | 6,612 Added 4.68% |
$8,529
$1.29 p/Share
|
Feb 23
2011 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 40 Added 0.01% |
$8,099
$202.48 p/Share
|
Feb 22
2011 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 300 Added 0.05% |
$60,000
$200.0 p/Share
|
Feb 22
2011 |
|
FCNCA
|
Holding Frank B Jr
Chairman and CEO |
BUY
Open market or private purchase
|
Indirect | 300 Added 1.51% |
$60,000
$200.0 p/Share
|
Feb 22
2011 |
|
ISR
|
Dwight William Babcock
CEO |
BUY
Open market or private purchase
|
Direct | 10,000 Added 4.86% |
$5,400
$0.54 p/Share
|
Feb 17
2011 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 178 Added 0.48% |
$35,566
$199.81 p/Share
|
Feb 11
2011 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,544 Added 30.93% |
$306,561
$198.55 p/Share
|
Feb 10
2011 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 100 Added 0.27% |
$20,090
$200.9 p/Share
|
Feb 10
2011 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 45 Added 0.01% |
$8,932
$198.5 p/Share
|
Feb 08
2011 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 100 Added 1.64% |
$20,100
$201.0 p/Share
|
Feb 08
2011 |
|
MEI
|
Timothy Glandon
Vice President |
BUY
Open market or private purchase
|
Direct | 21 Added 0.02% |
$248
$11.79 p/Share
|
Jan 28
2011 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 275 Added 2.69% |
$52,907
$192.39 p/Share
|
Jan 07
2011 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 300 Added 9.62% |
$59,010
$196.7 p/Share
|
Dec 31
2010 |
|
FCNCA
|
Irrevocable Trust Under Agreement Dated March 28 1990
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 200 Added 0.07% |
$39,612
$198.06 p/Share
|
Dec 23
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 240 Added 8.7% |
$45,600
$190.0 p/Share
|
Dec 22
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 33 Added 1.43% |
$6,250
$189.4 p/Share
|
Dec 20
2010 |
|
PRSO
|
Leonard Charles Perham
CEO |
BUY
Open market or private purchase
|
Direct | 275,000 Added 21.57% |
$1,204,500
$4.38 p/Share
|
Dec 10
2010 |
|
PRSO
|
Carl E Berg
Director |
BUY
Open market or private purchase
|
Direct | 230,000 Added 39.32% |
$1,007,400
$4.38 p/Share
|
Dec 10
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 98 Added 2.15% |
$18,437
$188.13 p/Share
|
Dec 10
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 75 Added 7.55% |
$13,783
$183.78 p/Share
|
Dec 07
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 319 Added 0.76% |
$58,122
$182.2 p/Share
|
Nov 30
2010 |
|
FCAP
|
Carolyn E Wallace
Director |
BUY
Open market or private purchase
|
Direct | 100 Added 50.0% |
$1,563
$15.63 p/Share
|
Nov 29
2010 |
|
IDIX
|
Ag Novartis |
BUY
Open market or private purchase
|
Indirect | 17,083 Added 0.01% |
$63,720
$3.73 p/Share
|
Nov 26
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 100 Added 4.48% |
$18,450
$184.5 p/Share
|
Nov 23
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 32 Added 2.66% |
$5,888
$184.0 p/Share
|
Nov 22
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 138 Added 10.82% |
$25,639
$185.79 p/Share
|
Nov 18
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 762 Added 50.0% |
$144,780
$190.0 p/Share
|
Nov 09
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 330 Added 0.9% |
$63,360
$192.0 p/Share
|
Nov 08
2010 |
|
FCAP
|
Pamela G Kraft
Director |
BUY
Open market or private purchase
|
Direct | 310 Added 43.06% |
$4,650
$15.0 p/Share
|
Nov 02
2010 |
|
VC
|
William E Redmond Jr
Director |
BUY
Open market or private purchase
|
Direct | 350 Added 20.59% |
$22,116
$63.19 p/Share
|
Nov 01
2010 |
|
VC
|
William E Redmond Jr
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 50.0% |
$63,000
$63.0 p/Share
|
Oct 29
2010 |
|
MEI
|
Timothy Glandon
Vice President |
BUY
Open market or private purchase
|
Direct | 26 Added 0.73% |
$242
$9.32 p/Share
|
Oct 29
2010 |
|
REGN
|
Sanofi |
BUY
Open market or private purchase
|
Indirect | 1,017,401 Added 6.04% |
$28,487,228
$28.0 p/Share
|
Oct 13
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 200 Added 0.08% |
$38,006
$190.03 p/Share
|
Oct 06
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 170 Added 2.79% |
$32,002
$188.25 p/Share
|
Oct 01
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,900 Added 34.01% |
$355,927
$187.33 p/Share
|
Sep 30
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 3,225 Added 35.95% |
$603,881
$187.25 p/Share
|
Sep 30
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 100 Added 3.82% |
$18,850
$188.5 p/Share
|
Sep 27
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 195 Added 7.46% |
$37,050
$190.0 p/Share
|
Sep 22
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 50 Added 2.2% |
$9,375
$187.5 p/Share
|
Sep 15
2010 |
|
AMKR
|
Roger Anthony Carolin
Director |
BUY
Open market or private purchase
|
Direct | 14,200 Added 26.01% |
$83,922
$5.91 p/Share
|
Sep 14
2010 |
|
AMKR
|
Roger Anthony Carolin
Director |
BUY
Open market or private purchase
|
Direct | 3,300 Added 8.99% |
$19,668
$5.96 p/Share
|
Sep 14
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 50 Added 2.25% |
$9,350
$187.0 p/Share
|
Sep 10
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 50 Added 2.11% |
$9,250
$185.0 p/Share
|
Sep 08
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 150 Added 6.19% |
$27,000
$180.0 p/Share
|
Sep 02
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 25 Added 1.16% |
$4,475
$179.0 p/Share
|
Aug 31
2010 |
|
FCNCA
|
Holding Frank B
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 100 Added 4.55% |
$17,900
$179.0 p/Share
|
Aug 30
2010 |
|
TZOO
|
Christopher Loughlin
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 100 Added 0.78% |
$1,570
$15.7 p/Share
|
Aug 27
2010 |